0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alcohol Use Disorder Market by Drug Class, Treatment Type, End User, Distribution Channel, Formulation - Global Forecast to 2030- Product Image
Alcohol Use Disorder Market by Drug Class, Treatment Type, End User, Distribution Channel, Formulation - Global Forecast to 2030- Product Image
Sale

Alcohol Use Disorder Market by Drug Class, Treatment Type, End User, Distribution Channel, Formulation - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967604
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Alcohol Use Disorder (AUD) market presents profound insights into the evolving landscape of AUD therapeutics, growing from USD 1.28 billion in 2024 to USD 1.37 billion in 2025. Projected to reach USD 1.88 billion by 2030 at a CAGR of 6.60%, this market analysis provides a comprehensive view into the challenges and opportunities within this critical healthcare sector.

Scope and Significance of Alcohol Use Disorder

Alcohol Use Disorder imposes significant pressure on global health and socioeconomic systems. This report delves into the multiple dimensions of AUD, from its clinical expressions to societal impacts and the shifting therapeutic landscape. The rise in prevalence rates is fueled by demographic shifts, evolving consumption patterns, and better diagnostics. As a result, a broad range of stakeholders is striving to innovate treatment models and improve accessibility.

The Evolving AUD Treatment Paradigm

The AUD treatment landscape is undergoing significant transformation. Digital health solutions like teletherapeutic platforms enhance adherence and extend the reach of behavioral therapies. Regulatory bodies are adapting approval pathways to integrate advanced treatment modalities such as sustained-release injectables and combination therapies. These changes accelerate the application of research innovations in clinical practices.

Strategic decisions in pharmaceutical developments and real-world evidence utilization enhance support services and tailor patient care. With the focus shifting toward personalized, outcome-oriented treatment approaches, stakeholders benefit from these insights through strategic planning, enabling a competitive edge in addressing shifting patient needs.

In-Depth Analysis of AUD Market Segmentation

The AUD therapeutics market is complexly segmented, offering strategic insights across various dimensions:

  • Drug Class: Acamprosate, Disulfiram, and Naltrexone, each with distinct administration routes appealing to diverse patient needs.
  • Treatment Type: Behavioral therapies like cognitive and family therapy, combined therapy regimens, and pharmacotherapy have distinctive patient applications.
  • End Users: Home healthcare, hospitals, rehabilitation centers, and specialty clinics cater to various therapeutic and care delivery needs.
  • Distribution Channels: Hospital and retail pharmacies, online platforms, and specialty pharmacies ensure diverse access points for patients.
  • Formulations: Options range from dispersible tablets to injectables, each tailored to specific patient and clinical requirements.

This segmentation framework allows for targeted market entry strategies, optimizing resource allocation to meet the nuanced needs of each sector.

Regional Dynamics Shaping the AUD Market

Regional factors significantly influence AUD treatment trajectories. The Americas exhibit robust adoption of pharmacotherapies backed by substantial public funding. In contrast, Europe, the Middle East, and Africa feature diversified market maturity levels, with local regulatory frameworks influencing innovation adoption. The Asia-Pacific region is characterized by rapid urbanization and evolving cultural perspectives on alcohol use, emphasizing the necessity for tailored market penetration strategies.

Understanding these regional dynamics aids stakeholders in adapting their approaches to align with local regulatory environments, payer structures, and patient preferences, providing competitive advantage in market entry and expansion endeavors.

Competitive Landscape and Key Industry Players

The competitive scenario in AUD therapeutics is marked by established pharmaceutical companies and emerging biotech innovators. Companies are leveraging strategic life-cycle management and acquisitions to strengthen market positions. New entrants are exploring novel delivery systems and partnership opportunities, while digital health start-ups integrate teletherapy platforms. As firms navigate regulatory pathways and secure favorable reimbursements, those that adeptly manage these dynamics stand to gain significant market leadership.

Key Takeaways from This Report

  • Shifts in treatment paradigms and regulatory adaptations enhance AUD therapeutic efficacy and accessibility.
  • Market segmentation insights enable strategic market penetration and personalized patient engagement.
  • Regional variations highlight the need for customized market strategies.
  • Competitive dynamics underscore the importance of agility and collaboration in sustaining market advantage.

Assessing the Impact of 2025 United States Tariffs on AUD Therapies

The 2025 imposition of U.S. tariffs has impacted global supply chains for AUD therapies, prompting a critical reassessment of sourcing and cost structures. Elevated raw material costs compel manufacturers to adjust procurement strategies and invest in domestic capabilities. Strategic industry collaborations aim to maintain supply continuity and access, emphasizing the intricate balance between trade policies and therapeutic availability.

Concluding Perspectives on AUD Market Evolution

The dynamic interplay of clinical innovation, regulation, and patient expectations drives the evolution of the AUD therapeutics market. Forward-thinking strategies involving digital and behavioral integration, as well as investment in collaborative frameworks, are imperative for continued growth. Organizations harmonizing strategic foresight with operational excellence will emerge as leaders, ensuring improved patient outcomes and optimized return on investment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Alcohol Use Disorder Market, by Drug Class
8.1. Introduction
8.2. Acamprosate
8.2.1. Effervescent Tablet
8.2.2. Oral Tablet
8.3. Disulfiram
8.3.1. Oral Tablet
8.4. Naltrexone
8.4.1. Injectable
8.4.2. Oral Tablet
9. Alcohol Use Disorder Market, by Treatment Type
9.1. Introduction
9.2. Behavioral Therapy
9.2.1. Cognitive Behavioral Therapy
9.2.2. Family Therapy
9.2.3. Motivational Enhancement Therapy
9.3. Combined Therapy
9.3.1. Cbt With Pharmacotherapy
9.3.2. Met With Pharmacotherapy
9.4. Pharmacotherapy
9.4.1. Injectable Drugs
9.4.2. Oral Drugs
10. Alcohol Use Disorder Market, by End User
10.1. Introduction
10.2. Home Healthcare
10.2.1. Home Visits
10.2.2. Telehealth
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Rehabilitation Centers
10.4.1. Inpatient
10.4.2. Outpatient
10.5. Specialty Clinics
10.5.1. Alcohol Rehabilitation Clinics
10.5.2. Psychiatric Clinics
11. Alcohol Use Disorder Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Private Hospital Pharmacies
11.2.2. Public Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. E-Commerce Websites
11.3.2. Mobile Apps
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
11.5. Specialty Pharmacies
11.5.1. Aud Specialty Pharmacies
11.5.2. General Specialty Pharmacies
12. Alcohol Use Disorder Market, by Formulation
12.1. Introduction
12.2. Dispersible Tablet
12.3. Effervescent Tablet
12.4. Injectable
12.4.1. Intramuscular
12.4.2. Intravenous
12.4.3. Subcutaneous
12.5. Oral Tablet
12.5.1. Immediate Release
12.5.2. Sustained Release
13. Americas Alcohol Use Disorder Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Alcohol Use Disorder Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Alcohol Use Disorder Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Alkermes plc
16.3.2. H. Lundbeck A/S
16.3.3. Teva Pharmaceutical Industries Ltd.
16.3.4. Viatris Inc.
16.3.5. Sandoz International GmbH
16.3.6. Dr. Reddy’s Laboratories Ltd.
16.3.7. Sun Pharmaceutical Industries Ltd.
16.3.8. Aurobindo Pharma Ltd.
16.3.9. Lupin Limited
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ALCOHOL USE DISORDER MARKET MULTI-CURRENCY
FIGURE 2. ALCOHOL USE DISORDER MARKET MULTI-LANGUAGE
FIGURE 3. ALCOHOL USE DISORDER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ALCOHOL USE DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FAMILY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CBT WITH PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MET WITH PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME VISITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL REHABILITATION CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PSYCHIATRIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY AUD SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY GENERAL SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISPERSIBLE TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 122. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 123. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 124. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 125. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 126. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 128. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 129. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 130. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 132. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 134. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 135. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 137. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 139. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 140. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 141. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. CANADA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 143. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 146. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 149. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 150. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 151. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 153. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 159. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 161. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 163. MEXICO ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 249. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 250. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 251. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 252. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 253. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 255. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 256. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 257. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 259. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 260. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 261. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 262. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 264. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 265. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 267. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 268. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 269. GERMANY ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 270. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 271. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 272. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 273. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 274. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 275. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 276. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 277. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 278. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 280. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 282. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 283. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 285. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 286. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 287. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 288. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 289. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 290. FRANCE ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 310. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 311. RUSSIA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 312. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 313. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2030 (USD MILLION)
TABLE 314. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, 2018-2030 (USD MILLION)
TABLE 315. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2030 (USD MILLION)
TABLE 316. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 317. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 318. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2030 (USD MILLION)
TABLE 319. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 320. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 322. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 323. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2030 (USD MILLION)
TABLE 324. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 325. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 327. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 328. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 329. ITALY ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 330. ITALY ALCOHOL USE DISORDER MARKET

Companies Mentioned

The companies profiled in this Alcohol Use Disorder market report include:
  • Alkermes plc
  • H. Lundbeck A/S
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Ltd.
  • Lupin Limited
  • Cipla Limited

Methodology

Methodology DOWNLOAD NOW

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.88 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Alcohol Use Disorder - Pipeline Insight, 2025 - Product Image

Alcohol Use Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Alcohol Abuse Monitoring Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Alcohol Abuse Monitoring Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
EUR$4,145USDGBP
Alcohol Addiction Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Alcohol Addiction Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 94 Pages
  • Global
From
EUR$4,145USDGBP
Alcohol Addiction - Pipeline Insight, 2025 - Product Image

Alcohol Addiction - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Addiction Disorders Drugs Market by Indication, Product Type, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Addiction Disorders Drugs Market by Indication, Product Type, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP

About the Alcoholism Market

Alcoholism is a form of drug abuse that is characterized by a strong craving for alcohol and an inability to control its consumption. It is a chronic, progressive disorder that can lead to physical, psychological, and social problems. Drug abuse screening is a process used to identify individuals who are at risk for developing an alcohol or drug problem. Screening typically involves a questionnaire or interview that assesses an individual's drinking habits, family history of substance abuse, and other risk factors. Screening for alcohol abuse is an important part of the prevention and treatment of alcoholism. It can help identify individuals who are at risk for developing an alcohol problem and provide them with the necessary resources to prevent or reduce their alcohol consumption. Screening can also help identify individuals who are already suffering from alcohol abuse and provide them with the necessary treatment and support. Companies in the Alcoholism market include Alcoholics Anonymous, Al-Anon, and SMART Recovery. Other organizations that provide support and resources for individuals with alcohol abuse issues include the National Institute on Alcohol Abuse and Alcoholism, the Substance Abuse and Mental Health Services Administration, and the American Society of Addiction Medicine. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more